Sword Health
$2Bpaper valuation
// OVERVIEW
Sword Health is the only digital physical therapy company that convinced insurers to pay $500 per patient for an AI-powered app and motion-tracking sensor while traditional PT costs $1,200 for in-person sessions — and the entire $2 billion valuation rests on whether payers keep believing the 62% cost reduction claim or start asking why outcomes data remains proprietary.
// HQ
Porto, Portugal
// STATUS
PRIVATE
// FOUNDED
2015
// TIER
The Unicorn Herd · $1B – $9.9B
// PRIMARY SECTOR
healthtech
// FOUNDERS
// FUNDING ROUNDS
// SECTORS SERVED
// TECHNOLOGY
Motion-tracking sensors paired with computer vision algorithms guide patients through physical therapy exercises at home, with periodic remote check-ins from licensed therapists. The AI detects movement patterns and corrects form in real-time. The technology works — the question is whether it works well enough to justify permanent displacement of in-person care or just serves as triage before patients eventually need a real clinic.
// WOWLS ASSESSMENT
Sword built a $2 billion business by solving the physical therapy access problem for large employers and insurers who care more about cost reduction than clinical outcomes. The company claims 62% cost savings versus traditional PT and has signed contracts covering 15 million lives across Fortune 500 employers. Two structural problems: competitors like Hinge Health raised $800 million on the same thesis and have equivalent payer penetration, and the entire category depends on sustained reimbursement rates that could evaporate if outcomes data shows high recidivism or delayed progression to surgery. The company has not published peer-reviewed clinical trial data comparing long-term outcomes to in-person PT — just internal metrics showing patient satisfaction and short-term pain reduction.
// WHY WOWLS HUNTS THIS
The reimbursement model is the entire moat and competitors are bidding down contract rates to steal employer accounts. When the category commoditizes the revenue per covered life compresses and $2 billion starts looking like $2 billion too much.
// VALUATION NOTE
Valuation confirmed at $2B from August 2021 Series D. No subsequent rounds disclosed publicly — valuation may reflect 2021 digital health peak pricing rather than current market.
VERDICT: ARMED — THE $2B VALUATION REQUIRES BELIEVING THAT INSURERS WILL KEEP PAYING FOR DIGITAL PT AT CURRENT RATES AFTER HINGE HEALTH, OMADA, AND PHYSERA ALL OFFER FUNCTIONALLY IDENTICAL PRODUCTS TO THE SAME EMPLOYER ACCOUNTS
// PACK DEBATE
// PACK DEBATE — be the first to weigh in
Google account required — no spam, no nonsense
// LOADING INTEL…
// BROADCAST INTEL
// SIMILAR TARGETS
// INTEL UPDATED: MAY 2026
// INTELLIGENCE DISCLAIMER: Assessments represent editorial opinion based on publicly available data including filings, press reports, and market data as of the date shown. Valuations are approximate. Not financial or investment advice.
// FULL NETWORK ACCESS
🚀 Founder Briefing: Instantly sort investors by Sector, Stage, & Round — direct links to websites for all 1,030 unicorns & backing VCs included.
Don't just track Sword Health.
Master the entire 1,030 unicorn company intelligence network.
Stop analyzing tech monopolies one page at a time. Instantly filter, sort, and isolate the exact venture capital firms, angel investors, and corporate funds backing your specific market vertical. Find investors that fit your sector and deploy your pitch with direct outbound links to every target asset in the database — 1,030 targets total.
Acquire Intel →// 5 TIERS · PAYPAL SECURED
// ENGAGE THE FULL ARSENAL
Done reading on Sword Health?
Unlock the entire 1,030-company hitlist and 1,030 investor contacts.
Full structural breakdowns. Founder dossiers. VC outreach data. Threat-level intel updated continuously.
→ Deploy 5-Tier Order Form// ARBAN · ZUUN · MINGHAN · TUMEN · KHAN